CE vs EMBC · rev $10.28B vs P/E 12, rev $1.08B
Celanese Corporation (CE) versus Embecta Corp (EMBC) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Embecta Corp (EMBC) is a medical instruments & supplies company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported EMBC revenue for 2025-09-30 was $1.08B. Net income was $95.4M. Revenue was down 3.8% from 2024-09-30 to 2025-09-30. EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
CE currently screens at market cap $5.92B. EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
Not investment advice. Open the CE and EMBC stock pages for the full models.
Not investment advice.